EcoDrugPlus

Lysyl Oxidase Homolog 2a-Like

Ensembl ID : ENSXMAG00000018377
Gene Symbol: LOC102236054
3 Cross references
209 Possible Orthologues:

Lysyl Oxidase Like 2

Ensembl ID : ENSXMAG00000010470
Gene Symbol: LOXL2
3 Cross references
211 Possible Orthologues:

Macrophage Colony-Stimulating Factor 1 Receptor 1-Like

Ensembl ID : ENSXMAG00000008588
Gene Symbol: LOC102233723
3 Cross references
63 Possible Orthologues:

Macrophage Colony-Stimulating Factor 1 Receptor 2

Ensembl ID : ENSXMAG00000006342
Gene Symbol: LOC102229494
2 Cross references
204 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSXMAG00000024562
Gene Symbol: MIF
3 Cross references
229 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSXMAG00000002163
Gene Symbol: MST1R
2 Cross references
193 Possible Orthologues:

Macrophage-Stimulating Protein Receptor-Like

Ensembl ID : ENSXMAG00000016479
Gene Symbol: LOC102220769
2 Cross references
188 Possible Orthologues:

Mast Cell Protease 1a-Like

Ensembl ID : ENSXMAG00000012370
Gene Symbol: LOC106699834
2 Cross references
961 Possible Orthologues:

Mast/stem Cell Growth Factor Receptor Kita-Like

Ensembl ID : ENSXMAG00000017634
Gene Symbol: LOC102237809
3 Cross references
200 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSXMAG00000027356
Gene Symbol: MMP1
4 Cross references
279 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSXMAG00000021837
Gene Symbol: MMP1
3 Cross references
278 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSXMAG00000007790
Gene Symbol: MMP2
3 Cross references
209 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).